TuHURA Biosciences (HURA) Assets (2011 - 2026)
TuHURA Biosciences (HURA) posted quarterly Assets of $29.7 million for Q1 2026, up 102.92% year-over-year from $14.6 million in Q1 2025, and up 8.6% quarter-over-quarter from $27.4 million in Q4 2025.
TuHURA Biosciences (HURA) Assets (2011 - 2026) Analysis & Trends
TuHURA Biosciences' Assets history runs 16 years deep, the most recent figure standing at $29.7 million for Q1 2026.
- In Q1 2026, Assets rose 102.92% year-over-year to $29.7 million; the TTM figure through Mar 2026 stood at $29.7 million (up 102.92% YoY), while the FY2025 annual figure was $27.4 million, up 36.99% from the prior year.
- Assets for Q1 2026 stood at $29.7 million, up from $27.4 million in the prior quarter.
- The five-year high for Assets was $34.6 million in Q2 2025, with the low at $1.5 million in Q3 2023.
- The 5-year median for Assets is $12.8 million (2022), against an average of $14.0 million.
- The sharpest annual moves came in 2023 and 2025: Assets plunged 88.82% in 2023, then jumped 520.7% in 2025.
- TuHURA Biosciences' Assets stood at $9.9 million in 2022, then sank by 56.02% to $4.4 million in 2023, then surged by 357.76% to $20.0 million in 2024, then surged by 36.99% to $27.4 million in 2025, then gained by 8.6% to $29.7 million in 2026.
- Business Quant data shows HURA's Assets at $29.7 million in Q1 2026, $27.4 million in Q4 2025, and $25.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | 31.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.70 Mn |
| Dec 31, 2025 | 27.35 Mn |
| Sep 30, 2025 | 25.70 Mn |
| Jun 30, 2025 | 34.62 Mn |
| Mar 31, 2025 | 14.64 Mn |
| Dec 31, 2024 | 19.97 Mn |
| Sep 30, 2024 | 4.14 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 7.45 Mn |
| Dec 31, 2023 | 4.36 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Jun 30, 2023 | 3.98 Mn |
| Mar 31, 2023 | 6.74 Mn |
| Dec 31, 2022 | 9.92 Mn |
| Sep 30, 2022 | 13.21 Mn |
| Jun 30, 2022 | 15.95 Mn |
| Mar 31, 2022 | 12.80 Mn |
| Dec 31, 2021 | 17.72 Mn |
| Sep 30, 2021 | 22.34 Mn |
| Jun 30, 2021 | 13.54 Mn |